LR
Laurence Reid

Laurence Reid insider trades: Metagenomi Therapeutics (MGX) stock buys and sales

Metagenomi Therapeutics Last trade Sep 9, 2026 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$23K
Bought, last 12 months
1 buy
10
Open-market trades
since 2012
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Laurence reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 9, 2026MGX↑ Buy$23K
Sep 15, 2021DBTX↑ Buy$76K
Nov 18, 2014ALNY↓ Sell$907K
Aug 18, 2014ALNY↓ Sell$909K
May 19, 2014ALNY↓ Sell$781K
Feb 19, 2014ALNY↓ Sell$1.6M
Nov 13, 2013ALNY↓ Sell$720K
May 28, 2013ALNY↓ Sell$150K
Feb 8, 2013ALNY↓ Sell$125K
Feb 21, 2012ALNY↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MGX insiders

Open-market trades in the last 12 months

About Laurence Reid's insider trades

Laurence Reid is an insider at Metagenomi Therapeutics (MGX). Since Feb 21, 2012, Laurence has reported 3 open-market purchases worth $110K and 7 sales worth $5.2M on SEC Form 4. In the last 12 months: 1 buy ($23K).

Their filings also include grants and awards (12 filings), option exercises (9 filings), shares withheld for taxes (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.